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Abstract
Background: laminectomy is a valuable surgical treatment for some patients with a cervical
radiculomyelopathy due to cervical spinal stenosis. More recently attention has been given to
motion of the spinal cord over spondylotic spurs as a cause of myelopathic changes. Immobilisation
by fusion could have a positive effect on the recovery of myelopathic signs or changes. This has
never been investigated in a prospective, randomised trial. Lamifuse is an acronyme for
laminectomy and fusion.
Methods/Design: Lamifuse is a multicentre, randomised controlled trial comparing laminectomy
with and without fusion in patients with a symptomatic cervical canal stenosis. The study population
will be enrolled from patients that are 60 years or older with myelopathic signs and/or symptoms
due to a cervical canal stenosis. A kyphotis shape of the cervical spine is an exclusion criterium.
Each treatment arm needs 30 patients.
Discussion: This study will contribute to the discussion whether additional fusion after a cervical
laminectomy results in a better clinical outcome.
ISRCT number: ISRCTN72800446
Background
Cervical spondylosis is a progressive degenerative disease
of the spine. As people grow older, the prevalence of cer-
vical spondylosis increases. It is a natural process of aging.
Cervical spondylosis is seen in 10% of individuals in the
age of 25 years, whereas in 95% of the persons of 65 years
[1].
Due to the degenerative process reduction of height of the
intervertebral discs, formation of spondylophytes and
sometimes instability occurs. This may lead to a stenosis
of the cervical spinal canal. In most instances it will
remain asymptomatic. However, in some persons the ste-
nosis of the spinal canal leads to a compression of the spi-
nal cord. It is important to realize that not only static
compression leads to neurological symptoms, but also
dynamic factors do. In a normal situation the spinal cord
will move during flexion and extension. Ventral osteo-
phytes in the spinal canal prevent up – and downward
movement [1]. Furthermore, the spinal cord is more
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stretched over the anterior bars increasing axial tension
within the spinal cord. These forces are multidirectional
creating secondary shearing forces resulting in stretch and
shear injury to myelin and neural elements [2-4].
Patients may present with a diversity of well known signs
and symptoms with variable intensities. Disturbance of
the sensibility in the arms, clumsiness of the hands and
problems with micturation may occur. However, the hall-
mark symptoms are gait abnormalities, weakness of the
legs or stiffness of the legs [1,5].
The natural course of the cervical myelopathy is variable.
But patients developing mild or moderate symptoms are
less likely to improve spontaneously. Non operative treat-
ment will mainly affect neck pain or accompanying radic-
ulopathy. Improvement has been noted but is variable
[6,7]. Patients with myelopathic signs and symptoms will,
however, likely benefit from surgery [5,7,8].
Surgical approaches for cervical myelopathy due to cervi-
cal spondylosis can be anterior, posterior or combined.
The last option is reserved for deformity correction. In
most instances a lordotic or slight kyphotic cervical spine
is present. The choice for an anterior or posterior
approach is dependent on the main site of compression,
the shape of the cervical sagittal curvature and to a lesser
account on the preference of the surgeon.
Dorsal approaches are laminectomy or laminoplasty. A
difference in clinical outcome has never been established.
Prevention of post – laminectomy kyphosis is a reason for
laminoplasty. If an additional, instrumented dorsal
fusion is performed, the change of developing a post-sur-
gical kyphosis is nearly zero[9]. It should be memorized
that spondylotic processes also generate reduced motion
of the spinal segments, a natural course [1]. From this
point of view, decompression with fusion will have better
clinical results when compared to decompression solely.
In literature, indications in this direction are found. Fre-
quently used dorsal fusion techniques today use lateral
mass screws and cervical pedicle screws. This is relatively
safe with a minimal persistent complication rate. Further-
more, in experienced hands these techniques do not add
substantial time to the duration of the surgery [7,9].
Despite a long-lasting interest in the various techniques,
the clinical superiority of one method over the other has
never been established. To our knowledge, a randomized
controlled trial comparing laminectomy with or without
fusion has never been performed.
Methods/Design
Hypothesis
Patients that are surgically treated for signs and symptoms
due to a stenosis of the cervical spinal canal have a better
clinical outcome when a dorsal fusion is performed in
addition to a laminectomy compared to those that have
solely a laminectomy.
At the end of the study, the quality of life, complications,
and the costs will be evaluated comparing these two treat-
ment groups.
In – and exclusion criteria
Patients with a minimal age of 60 years are included
(Table 1). At neurologic examination myelopathic
changes must be apparent. At magnetic resonance imag-
ing, concordant stenotic alterations at the cervical level(s)
must be present. At the plain sitting lateral radiograph a
lordotic spine must be shown. The shape of the cervical
spine is lordotic when the vertebral bodies of C3 to C6 are
in front of a line drawn from a point of the posterior infe-
rior part of the vertebral body of C2 to a point at the pos-
terior superior part of the vertebral body of C7 (Figure 1).
Only patients that sign the informed consent after some
time of reflection (1 week) are included.
Clinical evaluation and follow up
At the first intake, duration of symptoms, other diseases,
severity of signs and symptoms are noted. Neurologic
examination is performed by an independent neurologist.
At follow up, the severity of signs and symptoms are also
noted. Special attention is given to the myelopathic
Line from the posterior inferior part of the vertebral body of  C2 to the posterior superior part o f the vertebral body of  C7 in case of a normal cervical lordotic curvature (A) and a  kyphotic cervical curve (B) Figure 1
Line from the posterior inferior part of the vertebral body of 
C2 to the posterior superior part o f the vertebral body of 
C7 in case of a normal cervical lordotic curvature (A) and a 
kyphotic cervical curve (B).BMC Musculoskeletal Disorders 2007, 8:111 http://www.biomedcentral.com/1471-2474/8/111
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changes in arms and/or legs. Furthermore, the clinical sit-
uation is evaluated by the modified Japanese Orthopaedic
Association functional score[10] translated into the Dutch
language. The validation of the Dutch translation is cur-
rently subject of investigation. Finally, a change in the
quality of life is evaluated by the Dutch Short Form – 36
Health Survey.
Follow – up will be at six weeks, six months, and after one
year postoperatively (Table 2). Complications are noted
for their nature, duration and severity
Surgical technique
Cervical laminectomy of the compressed levels is per-
formed. Previous to the laminectomy a dorsal fusion is
done. Dorsal fusion includes lateral mass screws from C2
to C6. In C2, C7 and the upper thoracic spine levels, pedi-
cle screws will be placed. The screws are connected by rods
or plates. Transverse connectors are used when indicated.
In order to keep the posterior tension band intact, the
fusion will extend from one level above the planned most
cranial laminectomy level to at least one level below the
most caudal planned laminectomy site. If the lowest level
of fusion would include C7 or lower extension of the
fusion to the upper thoracic spine (Th2 or Th3) is recom-
mended[11]. This extension of the fusion is thought to
prevent junction disease at the cervicothoracic junction.
For example, if the laminectomy includes the levels C4 to
C6, the fusion would be from C3 to C7. Because C7 is the
lowest fusion level, incorporation of Th1 is recom-
mended.
Surgical demands
Since fusion is added, only centres with a known spinal
surgical experience are asked to participate. The surgeons
performing a laminectomy should also be experienced in
lateral mass fixation techniques, especially lateral mass
and cervical pedicle screws.
Study Sites
The following centres will paricipate: Radboud University
Nijmegen Medical Centre, Nijmegen; Canisius Wil-
helmina Hospital, Nijmegen; Medical Centre Haaglan-
den, The Hague; Sint Maartens Hospital, Nijmegen. All
Centres are located in the Netherlands. In all centres ethi-
cal approval is obtained.
Statistical analysis
The primary endpoint is clinical outcome after 1 year
using the modified Japanese Orthopaedic Association
functional score. Secondary outcomes are cost-effective-
ness, quality of life measured by the SF-36, and complica-
tions. Statistical analysis is performed by a blinded
investigator. For Statistical analysis the SAS system is used.
Descriptive statistics are used to describe baseline charac-
teristics. For comparison between groups student-t tests or
chi – square tests are used. Statistical significance is
reached when p < 0.05. Risk ratios (RR) and 95 % confi-
dence limits (CI) are presented. All analyses are done
according to the intention – to – treat principle
The minimal clinically important difference was esti-
mated by asking 4 international active spine surgeons
what they would consider a clinically significant differ-
ence in mJOA score. The mean of the values is considered
the MCID.
Table 2: overview of investigations at each clinical contact
Preoperative Postoperative (po) 6 weeks po 3 months po 1 year po
MRI X
Plain cervical radiograph XX X X X
mJOA XX X X
SF-36 XX X X
Neurologic examination by independent neurologist XX X
Table 1: in – and exclusioncriteria
Inclusion Exclusion
60 years or older Previous cervical surgery for 
myelopathic signs and symptoms
Cervical myelopathic 
symptoms and or signs at 
neurologic examination
Solely radiculopathy, or most 
important complaint
Stenosis of cervical spinal canal 
at MRI
Unable to undergo MRI
Lordotic shape at lateral 
cervical plain radiograph, or at 
lateral cervical radiograph in 
extension
Life expectancy less than 2 years
Informed consent Other diseases interfering with 
neurologic symptoms and signs, for 
example spinal cord glioma, thoracic 
herniated disc with spinal cord 
compression, multiple sclerosis etc.
Rheumatoid arthritis
Trauma to the neck in history
Diseases interfering with 
rehabilitation, for example severe 
cardiac congestive disease.
Participation in another studyBMC Musculoskeletal Disorders 2007, 8:111 http://www.biomedcentral.com/1471-2474/8/111
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The sample size is calculated as follows: a difference of at
least two points on the modified JOA functional score is
considered significant. The difference is expected to be
mainly allocated to the function of the arms and legs.
Based on literature, a standard deviation of approximately
2 is assumed [12]. A two group student t test with a 0.05
two sided significance level and a power of 95 % will need
a sample size per group of 27 to detect a significant differ-
ence. Considering a ten percent of lost to follow up, a total
of 30 individuals per group will be included.
Randomisation
For randomisation, the closed envelope method is used.
As soon as informed consent is obtained, one of the treat-
ment options is assigned to the patient. The secretary of
the neurosurgical department in the Canisius Wilhelmina
Hospital, Nijmegen, the Netherlands will control the ran-
domisation. Prior to surgery, the patient is informed
about the chosen option. Patients who do not choose for
participation, are offered one of the surgical options that
are currently under investigation. However, they are not
followed in an observational cohort study.
Endpoints
Primary endpoints
Several score systems exist for grading the severity of cer-
vical myelopathy. The modified Japanese Orthopedic
functional score (Fig. 2) evaluates four groups: the func-
tion of the arms, of the legs, the micturation, and the sen-
sibility of the hands. It has the major advantage that it
assesses these functions separately [10]. Although it has
been established that outcome after decompressive sur-
gery reaches a plateau at six months postoperatively [13],
the primary endpoint will be evaluated at one year post-
operatively just to make sure.
Secondary endpoints
Since instrumentation is added in the fusion group, the
costs will be higher. On the other hand, it is assumed that
a mean better recovery will take place in the fusion group.
Therefore, the additional costs (nursing costs, auxillary
supports, etc.) may be lower. A careful evaluation of the
costs of the treatment related to the outcome is per-
formed. To obtain a reliable insight in the costs the fol-
lowing will be noted in a kind of diary: hospitalisation,
out – patient contacts, additional medication, house
keeping support, instruments to support daily activities,
e.g. walking, eating etcetera. Of each item the sort and
amount will be recorded.
Apart from the cost – effectiveness, the difference in the
general health status will be evaluated. It is assumed that
general health will improve more after of a laminectomy
with a fusion than one without. This will be reflected in a
difference of the SF – 36 score. The Short Form 36 Health
Status Questionnaire is a widely-used generic health sta-
tus. This instrument consists of eight subscales and two
summary scales. On each scale higher scores indicate bet-
ter outcomes. Scores can be compared with published age
– and sex – matched general population or disease-spe-
cific norms [14]. Furthermore, it has been validated for
cervical spondylotic myelopathy [15].
Complications are separately registered. Complications
related to the cervical myelopathy are postoperative hem-
orrhage, postoperative infection, temporary or permanent
impairment of neurologic function, and kyphotic defor-
mation of the cervical spine[7]. Complications related to
adding lateral mass screws or/and pedicle screws are ver-
tebral artery injury and temporary or permanent nerve
root damage[7]. In order to prevent damage to the spinal
Modified Japanese Orthopaedic Association functional score Figure 2
Modified Japanese Orthopaedic Association functional score.
I. Motor dysfunction score of the upper extremities 
Inability  to  move  hands          0 
Inability to eat with a spoon but able to move hands       1 
Inability to button shirt but able to eat with a spoon       2 
Able to button shirt with great difficulty         3 
Able to button shirt with slight difficulty         4 
No  dysfunction           5 
II. Motor dysfunction score of the lower extremities
Complete loss of motor and sensory function         0 
Sensory preservation without ability to move legs       1 
Able to move legs but unable to walk           2 
Able to walk on flat floor with a walking aid (i.e., cane or crutch)    3 
Able to walk up and/or down stairs with hand rail       4 
Moderate to significant lack of stability but able to       5 
walk up and/or down stairs without hand rail 
Mild lack of stability but walk unaided with smooth reciprocation  6 
No  dysfunction           7 
III. Sensation
Complete loss of hand sensation           0 
Severe sensory loss or pain             1 
Mild  sensory  loss          2 
No  sensory  loss         3 
IV. Sphincter dysfunction score
Inability  to  micturate  voluntarily        0 
Marked  difficulty  with  micturition        1 
Mild to moderate difficulty with micturition         2 
Normal  micturition          3 BMC Musculoskeletal Disorders 2007, 8:111 http://www.biomedcentral.com/1471-2474/8/111
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cord, the instrumentation should be completed before the
laminectomy.
Monitored events
Monitored events are the death of a patient, withdrawal
from the study, lost to follow – up, and cross – over from
their randomly assigned treatment group. These events are
registered within the case record form. The circumstances
of the events are investigated and also noted. In case of
death of the patient, a search for a relationship with the
instituted treatment is started. Throughout the study, all
medical complications and intervening treatments con-
cerning the cervical spine are registered within the CRF at
the usual follow – up visits or when the appropriate infor-
mation reaches the treating surgeon.
Protocol violations
Any of the following will be considered as a deviation
from the protocol: randomization of an ineligible patient,
enrollment of a patient that is already participating in an
another study, enrollment of an participant to this study
in another study, a patient receiving the wrong treatment,
loss of radiology or any other data, and informed consent
violations. Violations are reviewed monthly and reported
to the independent study supervisor (R.D. Donk, M.D.,
Canisius Wilhelmina Hospital, Nijmegen).
Subject confidentiality
The anonymity of the subjects will be maintained. Sub-
jects will be identified by their initials and a subject
number assigned by the secretary of the neurosurgical
department in the Canisius Wilhelmina Hospital,
Nijmegen, the Netherlands. All CRFs and other docu-
ments submitted to the investigator will be assigned this
code. The secretary will enter the data of the patient and
their assigned code. This list is only accessible for the prin-
cipal investigator, and the independent supervisor.
Discussion
Movement as an cause additional to stenosis of cervical
myelopathy has been recognised for longer time. A posi-
tive effect of fusion in addition to decompression by lam-
inectomy has been reported earlier. To our knowledge, the
is the first randomised controlled trial comparing lami-
nectomy without and with dorsal instrumented fusion.
Apart from the clinical effectiveness, a study is needed to
explore the costeffectiveness of the treatments.
Several problems may arise. Randomization may be
refused by some patients. However, experience from ear-
lier trials learned that after correct description of the pos-
sibilities and estimated outcomes patients will not be
reluctant to be enrolled.
Through the age restriction, the results of the study cannot
be generalized to the whole population. However, most
often the patients with a symptomatic, degenerative, cer-
vical spinal canal stenosis will be 60 years old or older
[16].
Since knowledge of the instrumentation and of biome-
chanics of the cervical spine is necessary to avoid compli-
cations and to optimise instrumented fusion only
experienced spinal surgeons will collaborate with this
study. This will prevent a discussion related to the pre-
sumed different skill levels of the surgeons in case of an
unexpected result.
Finally, as a measure for the definitive clinical result the
mJOA is chosen. This is the only scale that takes the ambu-
latory function, the function of the hands, the sensibility
of the hands, and the micturation pattern separately into
account. This scale is validated for the Japanese popula-
tion [17]. However, its English translation has never been
validated. Now, the English mJOA has been translated
into Dutch. The validation of this translation is currently
under investigation.
Finally, Lamifuse tries to measure a difference in costs.
Since most of the patient will not be working anymore but
are retired, costs of material or personal support, extra
medication etcetera will be calculated. These costs are spe-
cific for the Netherlands, and cannot be extrapolated to
other countries.
Conclusion
Laminectomy for symptomatic cervical spinal stenisos is
frequently performed. However, not only compressive
forces are responsible for the complaints of the patient.
Continuing motion of the spinal cord over anterior
spondylophytic ridges is also believed to be a causative
factor. Fusion will prevent motion. This randomised, con-
trolled study will compare the clinical results of laminec-
tomy without and with fusion for patients with a
symptomatic stenosis of the cervical spinal canal. The
design of Lamifuse is discussed as are its limitations.
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